The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

BACKGROUND: Six months of adjuvant oxaliplatin-based chemotherapy is standard for patients with stage III colon cancer following surgery. However, oxaliplatin is associated with peripheral neurotoxicity which worsens over treatment duration. Consequently, a shorter treatment duration, if equally eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Oncol
Main Authors: Sobrero, A, Grothey, A, Iveson, T, Labianca, R, Yoshino, T, Taieb, J, Maughan, T, Buyse, M, André, T, Meyerhardt, J, Shields, A F, Souglakos, I, Douillard, J -Y, Cervantes, A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6864492/
https://ncbi.nlm.nih.gov/pubmed/29438451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados